<?xml version="1.0" encoding="UTF-8"?>
<ref id="B34-pharmaceuticals-13-00096">
 <label>34.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Al-Tawfiq</surname>
    <given-names>J.A.</given-names>
   </name>
   <name>
    <surname>Momattin</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Dib</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Memish</surname>
    <given-names>Z.A.</given-names>
   </name>
  </person-group>
  <article-title>Ribavirin and interferon therapy in patients infected with the Middle East respiratory syndrome coronavirus: An observational study</article-title>
  <source>Int. J. Infect. Dis.</source>
  <year>2014</year>
  <volume>20</volume>
  <fpage>42</fpage>
  <lpage>46</lpage>
  <pub-id pub-id-type="doi">10.1016/j.ijid.2013.12.003</pub-id>
  <pub-id pub-id-type="pmid">24406736</pub-id>
 </element-citation>
</ref>
